ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 322 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $6,591,000 | +53.4% | 70,916 | -1.7% | 0.01% | +28.6% |
| Q3 2021 | $4,297,000 | -4.7% | 72,162 | +9.2% | 0.01% | +16.7% |
| Q2 2021 | $4,508,000 | +8.8% | 66,097 | +10.7% | 0.01% | +20.0% |
| Q1 2021 | $4,143,000 | -44.4% | 59,713 | -38.4% | 0.01% | 0.0% |
| Q4 2020 | $7,446,000 | +135.3% | 96,908 | +129.6% | 0.01% | 0.0% |
| Q3 2020 | $3,164,000 | +59.0% | 42,201 | +33.5% | 0.01% | +25.0% |
| Q2 2020 | $1,990,000 | -83.1% | 31,615 | -87.3% | 0.00% | -84.0% |
| Q1 2020 | $11,803,000 | +294.1% | 249,314 | +278.1% | 0.02% | +400.0% |
| Q4 2019 | $2,995,000 | -6.7% | 65,936 | -6.1% | 0.01% | -16.7% |
| Q3 2019 | $3,209,000 | +103.0% | 70,214 | +160.3% | 0.01% | +100.0% |
| Q2 2019 | $1,581,000 | – | 26,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |